Evaluation of the efficacy of glecaprevir and pibrentasvir for Japanese hepatitis C patients: a prospective study in real life settings.
Not Applicable
Recruiting
- Conditions
- cirrhotic and non cirrhotic patients with chronic hepatitis C virus
- Registration Number
- JPRN-UMIN000031664
- Lead Sponsor
- Toranomon Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
Not provided
Exclusion Criteria
decompensated cirrhosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virological response (SVR) at 12 week and 24 week after the end of treatment
- Secondary Outcome Measures
Name Time Method incidence rate of adverse events sustained virological response (SVR) at 4 week after the end of treatment